» Articles » PMID: 35947304

Endoscopic Ultrasound-Directed Transgastric ERCP (EDGE) Utilization of Trends Among Interventional Endoscopists

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2022 Aug 10
PMID 35947304
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endoscopic ultrasound-directed transgastric ERCP (EDGE) has become standard-of-care therapy at many centers for pancreaticobiliary disease in patients with Roux-en-Y Gastric Bypass. In this study, we aimed to evaluate the opinions and practices of endoscopists who perform EDGE.

Methods: A 22-question utilization of EDGE survey was sent to 36 advanced endoscopists at tertiary care centers in the United States. The two-section survey included questions regarding advanced endoscopy volume and training at the respective facilities, and questions on specific details of EDGE utilization.

Results: Among 36 interventional endoscopists (IE) surveyed, 14 (39%) reported performing > 1000 ERCPs annually. Thirty (83%) offered EDGE as an option for Roux-en-Y gastric bypass patients with previous cholecystectomy. Other options offered included: 19 (53%) offered Laparoscopy-assisted ERCP (LA-ERCP), 7 (19%) offered Single-Balloon ERCP (SBE), and 10 (28%) offered percutaneous drainage (PTC). Twenty (56%) IE performed 10 or less EDGE procedures, while 16 (44%) performed 11 or more. Single-session EDGE was performed by 7 (19%) IE, while 15 (42%) performed dual session, and 13 (36%) performed both. 19 (53%) actively closed fistulas while 17 (47%) let them close spontaneously. Thirty one (86%) reported a technical success rate of 91% to 100%. The most frequently reported immediate adverse event post-procedurally was abdominal pain, reported by 17 IE (47%). Weight gain was reported by 2 IE (6%).

Conclusion: EDGE continues to gain in popularity as an option for Roux-en-Y gastric bypass patients requiring pancreaticobiliary interventions, with 24/36 IE (67%) believing that it should be the new standard. In addition, most report a low frequency of post-procedural weight gain.

Clinical Trial Registration: ClinicalTrials.gov Identifier NCT05041608.

Citing Articles

.

Srivastava R, Moran R, Elmunzer B VideoGIE. 2024; 9(1):51-55.

PMID: 38239185 PMC: 10794120. DOI: 10.1016/j.vgie.2023.09.007.


Endoscopic treatment of bile duct stones after bariatric Roux-en-Y gastric bypass through endoscopic ultrasound-directed transgastric ERCP.

Vara-Luiz F, Nunes G, Pinto-Marques P, Oliveira C, Mendes I, Patita M Endoscopy. 2023; 55(S 01):E1065-E1067.

PMID: 37734414 PMC: 10513776. DOI: 10.1055/a-2161-3450.

References
1.
Kedia P, Sharaiha R, Kumta N, Kahaleh M . Internal EUS-directed transgastric ERCP (EDGE): game over. Gastroenterology. 2014; 147(3):566-8. DOI: 10.1053/j.gastro.2014.05.045. View

2.
Tyberg A, Nieto J, Salgado S, Weaver K, Kedia P, Sharaiha R . Endoscopic Ultrasound (EUS)-Directed Transgastric Endoscopic Retrograde Cholangiopancreatography or EUS: Mid-Term Analysis of an Emerging Procedure. Clin Endosc. 2016; 50(2):185-190. PMC: 5398356. DOI: 10.5946/ce.2016.030. View

3.
Ngamruengphong S, Nieto J, Kunda R, Kumbhari V, Chen Y, Bukhari M . Endoscopic ultrasound-guided creation of a transgastric fistula for the management of hepatobiliary disease in patients with Roux-en-Y gastric bypass. Endoscopy. 2017; 49(6):549-552. DOI: 10.1055/s-0043-105072. View

4.
Kedia P, Tarnasky P, Nieto J, Steele S, Siddiqui A, Xu M . EUS-directed Transgastric ERCP (EDGE) Versus Laparoscopy-assisted ERCP (LA-ERCP) for Roux-en-Y Gastric Bypass (RYGB) Anatomy: A Multicenter Early Comparative Experience of Clinical Outcomes. J Clin Gastroenterol. 2018; 53(4):304-308. DOI: 10.1097/MCG.0000000000001037. View

5.
James T, Baron T . Endoscopic Ultrasound-Directed Transgastric ERCP (EDGE): a Single-Center US Experience with Follow-up Data on Fistula Closure. Obes Surg. 2018; 29(2):451-456. PMC: 6550479. DOI: 10.1007/s11695-018-3531-2. View